Clinical validation of the Abbott RealTime High Risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening

A T Hesselink; C J L M Meijer; M Poljak; J Berkhof; F J van Kemenade; M L van der Salm; M Bogaarts; P J F Snijders; D A M Heideman

doi:10.1128/JCM.00633-13

Clinical validation of the Abbott RealTime High Risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening

A T Hesselink, C J L M Meijer, M Poljak, J Berkhof, F J van Kemenade, M L van der Salm, M Bogaarts, P J F Snijders, D A M Heideman^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Academic › peer-review

38 Citations (Scopus)

Abstract

This study showed that the Abbott RealTime High Risk HPV assay fulfilled cross-sectional clinical equivalence and reproducibility criteria of international consensus guidelines, which indicates that this assay can be considered clinically validated for cervical cancer screening purposes.

Original language	English
Pages (from-to)	2409-2410
Number of pages	2
Journal	Journal of Clinical Microbiology
Volume	51
Issue number	7
DOIs	https://doi.org/10.1128/JCM.00633-13
Publication status	Published - Jul-2013
Externally published	Yes

Keywords

Adult
DNA, Viral/genetics
Early Detection of Cancer/methods
Female
Humans
Middle Aged
Molecular Diagnostic Techniques/methods
Papillomaviridae/classification
Papillomavirus Infections/diagnosis
Real-Time Polymerase Chain Reaction/methods
Reproducibility of Results
Virology/methods

Access to Document

10.1128/JCM.00633-13

Clinical Validation of the Abbott RealTime High RiskFinal publisher's version, 84.1 KBLicence: Taverne

Handle.net

Persistent link

Cite this

Hesselink, A. T., Meijer, C. J. L. M., Poljak, M., Berkhof, J., van Kemenade, F. J., van der Salm, M. L., Bogaarts, M., Snijders, P. J. F., & Heideman, D. A. M. (2013). Clinical validation of the Abbott RealTime High Risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening. Journal of Clinical Microbiology, 51(7), 2409-2410. https://doi.org/10.1128/JCM.00633-13

@article{485932b1d75c4cc883a52c2ddae484a2,

title = "Clinical validation of the Abbott RealTime High Risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening",

abstract = "This study showed that the Abbott RealTime High Risk HPV assay fulfilled cross-sectional clinical equivalence and reproducibility criteria of international consensus guidelines, which indicates that this assay can be considered clinically validated for cervical cancer screening purposes.",

keywords = "Adult, DNA, Viral/genetics, Early Detection of Cancer/methods, Female, Humans, Middle Aged, Molecular Diagnostic Techniques/methods, Papillomaviridae/classification, Papillomavirus Infections/diagnosis, Real-Time Polymerase Chain Reaction/methods, Reproducibility of Results, Virology/methods",

author = "Hesselink, {A T} and Meijer, {C J L M} and M Poljak and J Berkhof and {van Kemenade}, {F J} and {van der Salm}, {M L} and M Bogaarts and Snijders, {P J F} and Heideman, {D A M}",

year = "2013",

month = jul,

doi = "10.1128/JCM.00633-13",

language = "English",

volume = "51",

pages = "2409--2410",

journal = "Journal of Clinical Microbiology",

issn = "0095-1137",

publisher = "AMER SOC MICROBIOLOGY",

number = "7",

}

Hesselink, AT, Meijer, CJLM, Poljak, M, Berkhof, J, van Kemenade, FJ, van der Salm, ML, Bogaarts, M, Snijders, PJF & Heideman, DAM 2013, 'Clinical validation of the Abbott RealTime High Risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening', Journal of Clinical Microbiology, vol. 51, no. 7, pp. 2409-2410. https://doi.org/10.1128/JCM.00633-13

Clinical validation of the Abbott RealTime High Risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening. / Hesselink, A T; Meijer, C J L M; Poljak, M et al.
In: Journal of Clinical Microbiology, Vol. 51, No. 7, 07.2013, p. 2409-2410.

Research output: Contribution to journal › Letter › Academic › peer-review

TY - JOUR

T1 - Clinical validation of the Abbott RealTime High Risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening

AU - Hesselink, A T

AU - Meijer, C J L M

AU - Poljak, M

AU - Berkhof, J

AU - van Kemenade, F J

AU - van der Salm, M L

AU - Bogaarts, M

AU - Snijders, P J F

AU - Heideman, D A M

PY - 2013/7

Y1 - 2013/7

N2 - This study showed that the Abbott RealTime High Risk HPV assay fulfilled cross-sectional clinical equivalence and reproducibility criteria of international consensus guidelines, which indicates that this assay can be considered clinically validated for cervical cancer screening purposes.

AB - This study showed that the Abbott RealTime High Risk HPV assay fulfilled cross-sectional clinical equivalence and reproducibility criteria of international consensus guidelines, which indicates that this assay can be considered clinically validated for cervical cancer screening purposes.

KW - Adult

KW - DNA, Viral/genetics

KW - Early Detection of Cancer/methods

KW - Female

KW - Humans

KW - Middle Aged

KW - Molecular Diagnostic Techniques/methods

KW - Papillomaviridae/classification

KW - Papillomavirus Infections/diagnosis

KW - Real-Time Polymerase Chain Reaction/methods

KW - Reproducibility of Results

KW - Virology/methods

U2 - 10.1128/JCM.00633-13

DO - 10.1128/JCM.00633-13

M3 - Letter

C2 - 23637297

SN - 0095-1137

VL - 51

SP - 2409

EP - 2410

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

IS - 7

ER -

Clinical validation of the Abbott RealTime High Risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening

Abstract

Keywords

Access to Document

Handle.net

Fingerprint

Cite this